Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 4,693-4,704 of 10,592
Drug study icon
WithdrawnNCT04311619

Does rTMS Induce Synaptic Plasticity?

This summary needs review. Please check the official study record and contact the research team for details.

In United States
DepressionDrugA study involving a medication or substance.From 18 Years to 70 Years
Countries
United States
Sponsor
Davidzon, Guido, M.D.
Condition
Depression
Drug study icon
WithdrawnNCT05060549

Dopamine D3 Receptor Occupancy in Depression in bipolarity

This study is looking at whether a digital support tool can help people with Depression in bipolarity. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Bipolarity, DepressionDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Bipolarity, Depression
Other study type icon
CompletedNCT01035996

Dopamine Function and Reward Processing In Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
SchizophreniaOtherFrom 18 Years to 50 Years
Countries
United States
Sponsor
National Institute on Drug Abuse (NIDA)
Condition
Schizophrenia
Other study type icon
CompletedNCT00116077

Dopamine Receptor Imaging in Mood Disorders

This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can better support energy, concentration, and everyday functioning.

Remote / online
Depression, BipolarityOtherFrom 18 Years to 55 Years
Countries
United States
Sponsor
National Institute of Mental Health (NIMH)
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT02225106

Dopamine Receptor Imaging to Predict Response to Stimulant Therapy in Chronic TBI

This study exists to understand what helps a therapy or guided support program work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a therapy or guided support program can improve attention, thinking, or day-to-day functioning.

In United States
ADHDDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
University of Pennsylvania
Condition
ADHD
Drug study icon
WithdrawnNCT02233829

Dopamine Rhythms in Health and Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AddictionDrugFrom 21 Years to 55 Years
Countries
United States
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Addiction
Drug study icon
CompletedNCT04469959

Dopaminergic Dysfunction in Late-Life Depression

This study is looking at whether L-Dopa can help people with depression. Participants take part in L-Dopa and complete follow-up assessments.

In United States
DepressionDrugOver 60 Years
Countries
United States
Sponsor
Vanderbilt University Medical Center
Condition
Depression
Drug study icon
CompletedNCT02255565

Dose Response Effects of Quillivant XR in Children With ADHD and Autism: A Study

This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.

In United States
ADHDDrugFrom 5 Years to 16 Years
Countries
United States
Sponsor
Seattle Children's Hospital
Condition
ADHD
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.